Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 5
2017 6
2018 4
2019 8
2020 9
2021 4
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis.
Sacco R, Ramai D, Tortora R, di Costanzo GG, Burlone ME, Pirisi M, Federico P, Daniele B, Silletta M, Gallo P, Cocuzza C, Russello M, Cabibbo G, Rancatore G, Cesario S, Masi G, Marzi L, Mega A, Granito A, Pieri G, Giannini EG, Paolillo R, Gadaleta-Caldarola G, Dadduzio V, Giordano G, Giacomelli L, Papa S, Renzulli M, Maida M, Ghidini M, Borzio M, Facciorusso A; A.I.G.O. (Italian Association of Hospital Gastroenterologists). Sacco R, et al. Among authors: dadduzio v. Cancers (Basel). 2023 Jan 6;15(2):381. doi: 10.3390/cancers15020381. Cancers (Basel). 2023. PMID: 36672330 Free PMC article.
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment.
Personeni N, Pressiani T, Zanuso V, Casadei-Gardini A, D'Alessio A, Valgiusti M, Dadduzio V, Bergamo F, Soldà C, Rizzato MD, Giordano L, Santoro A, Rimassa L. Personeni N, et al. Among authors: dadduzio v. J Pers Med. 2022 Oct 17;12(10):1726. doi: 10.3390/jpm12101726. J Pers Med. 2022. PMID: 36294865 Free PMC article.
Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress.
Gadaleta-Caldarola G, Rizzo A, Dadduzio V, Lombardi L, Gadaleta-Caldarola A, Infusino S, Cusmai A, Citrigno C, Palmiotti G. Gadaleta-Caldarola G, et al. Among authors: dadduzio v. Curr Oncol. 2022 Oct 19;29(10):7925-7931. doi: 10.3390/curroncol29100626. Curr Oncol. 2022. PMID: 36290903 Free PMC article.
Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study.
Rizzato M, Brignola S, Munari G, Gatti M, Dadduzio V, Borga C, Bergamo F, Pellino A, Angerilli V, Mescoli C, Guido M, Rearden J, Gringeri E, Cillo U, Dei Tos AP, Zagonel V, Loupakis F, Lonardi S, Fassan M. Rizzato M, et al. Among authors: dadduzio v. Eur J Cancer. 2022 May;166:165-175. doi: 10.1016/j.ejca.2022.02.013. Epub 2022 Mar 15. Eur J Cancer. 2022. PMID: 35303508
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma.
Tovoli F, Dadduzio V, De Lorenzo S, Rimassa L, Masi G, Iavarone M, Marra F, Garajova I, Brizzi MP, Daniele B, Trevisani F, Messina C, Di Clemente F, Pini S, Cabibbo G, Granito A, Rizzato MD, Zagonel V, Brandi G, Pressiani T, Federico P, Vivaldi C, Bergna I, Campani C, Piscaglia F. Tovoli F, et al. Among authors: dadduzio v. Liver Cancer. 2021 Jul;10(4):370-379. doi: 10.1159/000515551. Epub 2021 Jun 15. Liver Cancer. 2021. PMID: 34414124 Free PMC article.
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib.
Casadei-Gardini A, Rovesti G, Dadduzio V, Vivaldi C, Lai E, Lonardi S, Fornaro L, Pretta A, Zagonel V, Bernardini L, Astara G, D'Amico FE, Masi G, Rimini M, Scartozzi M, Cascinu S. Casadei-Gardini A, et al. Among authors: dadduzio v. HPB (Oxford). 2021 Jun;23(6):915-920. doi: 10.1016/j.hpb.2020.09.024. Epub 2020 Nov 12. HPB (Oxford). 2021. PMID: 33191108 Free article.
41 results